ArticlePhysiological reports2022

Factor Xa inhibitor, edoxaban ameliorates renal injury after subtotal nephrectomy by reducing epithelial-mesenchymal transition and inflammatory response.

Lixin Fang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.